Alzheimer's Institute Sues Pfizer Over Mice Patents

Law360, New York (July 1, 2009, 12:00 AM EDT) -- A biotechnology patent-holding company has sued Pfizer Inc. alleging the drugmaker infringed patents related to components of Alzheimer’s disease research, including nucleic acid coding for the so-called Swedish mutation and genetically engineered mice expressing the mutation.

The Alzheimer’s Institute of America Inc. filed its complaint on Tuesday in the U.S. District Court for the Eastern District of Missouri asserting that Pfizer has infringed U.S. Patent Numbers 5,455,169; 5,795,963; and 6,818,448 in the company’s own efforts to conduct research into potential treatment options for Alzheimer’s.

The institute,...
To view the full article, register now.